Digital technologies are now the predominant means of generating data, whether documents or raw and processed data. Addressing the formidable business and technical difficulties of preserving this information in digital form is now of prime importance and has been given legal force by the 21 CFR Part 11 ruling from the US Food and Drug Administration. Similar legislation is emerging elsewhere. For today’s organisations the emphasis must now be on excellence in archiving to stay compliant and to protect and preserve intellectual capital. This has become an urgent issue for the pharmaceutical industry.

Philip Lord provides management consultancy on digital asset preservation based on first-hand, practical experience in the industry. The consultancy provides strategic advice to senior management on how this issue can be addressed within the context of their particular own organisations. Practical support, advice and solutions are provided to companies on how to tackle this multi-faceted and complex, problem. With associates he can also provide practical assistance with building robust cost-effective digital archiving solutions, and with the management of the organisational impact to ensure that solutions are successful internally and meet external regulatory demands.